These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1680293)

  • 1. Physician opinion of pharmacist-initiated change from injectable to oral administration of histamine H2-receptor antagonists.
    Kirking DM; Bickley SK; Wasserman ML
    Am J Hosp Pharm; 1991 Aug; 48(8):1722-7. PubMed ID: 1680293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with a two-tiered therapeutic interchange policy.
    Rich DS
    Am J Hosp Pharm; 1989 Sep; 46(9):1792-8. PubMed ID: 2572167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician and pharmacist attitudes toward medication use.
    Bootman JL; Hurd PD; Gaines JA
    Am J Hosp Pharm; 1982 May; 39(5):818-21. PubMed ID: 7081254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician attitudes toward pharmacists counseling patients on adverse drug reactions.
    Moss RL; Garnett WR; Steiner KC
    Am J Hosp Pharm; 1980 Feb; 37(2):243-7. PubMed ID: 7361800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing whether a clinical pharmacy program is meeting its goals.
    Fink A; Kosecoff J; Oppenheimer PR; Smith WE; Brodie DC
    Am J Hosp Pharm; 1982 May; 39(5):806-10. PubMed ID: 7081251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nurses' attitudes toward pharmaceutical services before and after decentralization.
    Ross MB; Ryan ML
    Am J Hosp Pharm; 1988 Feb; 45(2):351-6. PubMed ID: 3364435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physicians' expectations towards pharmacy services on ward].
    Bourget S; Allenet B; Bedouch P; Bosson LJ; Calop J
    J Pharm Belg; 2007; 62(4):130-4. PubMed ID: 18269141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of direct pharmacist intervention on conversion from parenteral to oral histamine H2-receptor antagonist therapy.
    Kirking DM; Svinte MK; Berardi RR; Cornish LA; Chaffee BW; Ryan ML
    DICP; 1991 Jan; 25(1):80-4. PubMed ID: 1672572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions, experiences, and expectations of physicians in hospital settings in Jordan regarding the role of the pharmacist.
    Tahaineh LM; Wazaify M; Albsoul-Younes A; Khader Y; Zaidan M
    Res Social Adm Pharm; 2009 Mar; 5(1):63-70. PubMed ID: 19285290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist adjustment of H2-receptor antagonist dosage to meet medical staff-approved criteria.
    Malcolm KE; Griffin CR; Bennett TA; Robertson LM
    Am J Hosp Pharm; 1994 Sep; 51(17):2152-4. PubMed ID: 7985692
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacists' attitudes toward physician-assisted suicide.
    Rupp MT; Isenhower HL
    Am J Hosp Pharm; 1994 Jan; 51(1):69-74. PubMed ID: 8135261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician and patient perceptions of the route of administration of venous thromboembolism prophylaxis: results from an international survey.
    Cimminiello C; Anderson FA
    Thromb Res; 2012 Feb; 129(2):139-45. PubMed ID: 21816454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacist-initiated program of intravenous to oral antibiotic conversion.
    Przybylski KG; Rybak MJ; Martin PR; Weingarten CM; Zaran FK; Stevenson JG; Levine DP
    Pharmacotherapy; 1997; 17(2):271-6. PubMed ID: 9085318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-use review program for concurrent histamine H2-receptor antagonist-sucralfate therapy.
    Kane MP; Briceland LL; Garris RE; Favreau BN
    Am J Hosp Pharm; 1990 Sep; 47(9):2007-10. PubMed ID: 1977317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of exposure on physicians' attitudes toward clinical pharmacists.
    Ritchey FJ; Raney MR
    Am J Hosp Pharm; 1981 Oct; 38(10):1459-63. PubMed ID: 7294036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information on antineoplastic drugs for nononcologist physicians.
    Ballentine R; Primeaux J
    Am J Hosp Pharm; 1977 Aug; 34(8):839-43. PubMed ID: 900136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pharmacist participation on a medical team on costs, charges, and length of stay.
    Haig GM; Kiser LA
    Am J Hosp Pharm; 1991 Jul; 48(7):1457-62. PubMed ID: 1882873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' perceptions and knowledge of drug costs: results of a survey.
    Barclay LP; Hatton RC; Doering PL; Shands JW
    Formulary; 1995 May; 30(5):268-70, 272, 277-9. PubMed ID: 10151726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-based program for identifying medication orders requiring dosage modification based on renal function.
    Goldberg DE; Baardsgaard G; Johnson MT; Jolowsky CM; Shepherd M; Peterson CD
    Am J Hosp Pharm; 1991 Sep; 48(9):1965-9. PubMed ID: 1928142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
    Caldwell RD; Davis SK
    Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.